Literature DB >> 32361326

Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement.

Andrew B Fleming1, Vanessa Raabe2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32361326     DOI： 10.1016/j.jcv.2020.104388

Source DB:  PubMed          Journal:  J Clin Virol        ISSN： 1386-6532            Impact factor:   3.168


× No keyword cloud information.
  22 in total

Review 1.  Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines.

Authors:  Yinan Xiao; Hanyue Xu; Wen Guo; Yunuo Zhao; Yuling Luo; Ming Wang; Zhiyao He; Zhenyu Ding; Jiyan Liu; Lei Deng; Fushen Sha; Xuelei Ma
Journal:  Mol Biomed       Date:  2020-12-03

2.  Effect of Convalescent Plasma Therapy on Clinical Improvement of COVID-19 Patients: A Randomized Clinical Trial.

Authors:  Ebrahim Jalili; Salman Khazaei; Afshin Mohammadi; Fariba Keramat; Seyed Hamid Hashemi; Saeid Bashirian; Toos Kiani; Farid Azizi Jalilian; Samereh Ghelichkhani; Manoochehr Karami; Maryam Farrokhi; Rashid Heidarimoghadam; Tahereh Abbasi Garavand; Ebrahim Daneshyar; Mohammad Abbasi
Journal:  Tanaffos       Date:  2022-01

3.  Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.

Authors:  Henry T Peng; Shawn G Rhind; Andrew Beckett
Journal:  JMIR Public Health Surveill       Date:  2021-04-07

Review 4.  Convalescent plasma transfusion a promising therapy for coronavirus diseases 2019 (COVID-19): current updates.

Authors:  Henu Kumar Verma; Batoul Farran; Lakkakula V K S Bhaskar
Journal:  Antib Ther       Date:  2020-05-27

5.  Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?

Authors:  Olivier Garraud
Journal:  Transfus Apher Sci       Date:  2020-06-27       Impact factor: 1.764

6.  A potentially effective treatment for COVID-19: A systematic review and meta-analysis of convalescent plasma therapy in treating severe infectious disease.

Authors:  Mengyao Sun; Yinghui Xu; Hua He; Li Zhang; Xu Wang; Qing Qiu; Chao Sun; Ye Guo; Shi Qiu; Kewei Ma
Journal:  Int J Infect Dis       Date:  2020-07-04       Impact factor: 3.623

7.  Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study.

Authors:  Hassan Abolghasemi; Peyman Eshghi; Abdol Majid Cheraghali; Abbas Ali Imani Fooladi; Farzaneh Bolouki Moghaddam; Sina Imanizadeh; Matin Moeini Maleki; Mohammad Ranjkesh; Mohammad Rezapour; Ali Bahramifar; Behzad Einollahi; Mohammad Javad Hosseini; Nematollah Joneidi Jafari; Mohamad Nikpouraghdam; Nariman Sadri; Mokhtar Tazik; Shanaz Sali; Shamsi Okati; Elham Askari; Payam Tabarsi; Jafar Aslani; Ehsan Sharifipour; Mohammad Hossein Jarahzadeh; Nastaran Khodakarim; Mahmood Salesi; Ramezan Jafari; Samira Shahverdi
Journal:  Transfus Apher Sci       Date:  2020-07-15       Impact factor: 1.764

Review 8.  COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies.

Authors:  Abdur Rauf; Tareq Abu-Izneid; Ahmed Olatunde; Anees Ahmed Khalil; Fahad A Alhumaydhi; Tabussam Tufail; Mohammad Ali Shariati; Maksim Rebezov; Zainab M Almarhoon; Yahia N Mabkhot; Abdulrhman Alsayari; Kannan R R Rengasamy
Journal:  Int J Environ Res Public Health       Date:  2020-11-04       Impact factor: 3.390

9.  Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial.

Authors:  M L L Madariaga; J J Guthmiller; S Schrantz; M O Jansen; C Christensen; M Kumar; M Prochaska; G Wool; A Durkin-Celauro; W H Oh; L Trockman; J Vigneswaran; R Keskey; D G Shaw; H Dugan; N-Y Zheng; M Cobb; H Utset; J Wang; O Stovicek; C Bethel; S Matushek; M Giurcanu; K G Beavis; D di Sabato; D Meltzer; M K Ferguson; J P Kress; K Shanmugarajah; J B Matthews; J F Fung; P C Wilson; J C Alverdy; J S Donington
Journal:  J Intern Med       Date:  2020-11-03       Impact factor: 13.068

Review 10.  Cytokine storm induced by SARS-CoV-2.

Authors:  Peipei Song; Wei Li; Jianqin Xie; Yanlong Hou; Chongge You
Journal:  Clin Chim Acta       Date:  2020-06-10       Impact factor: 6.314
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.